The MOVE-Lp(a) study will test if an investigational medicine safely lowers Lp(a) levels and reduces the risk of heart disease or stroke.
Lipoprotein(a) is also known as Lp(a). Lp(a) is an important risk factor for heart disease and is largely determined by your genes.
Lp(a) carries cholesterol (a type of fat) in the blood. If you have a high level of Lp(a), you may have a higher risk for heart disease or stroke.
You may have a high level of Lp(a) even if you have a healthy lifestyle or are taking other medicine for your cholesterol
You may be able to join the study if you:
- are at least 18 years of age
- have a high level of Lp(a) in your blood
or
- are at risk for a first heart attack or stroke
The study will be conducted at your local FutureMeds clinic
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
